Concepedia
Statistics
Publications
88
Citations
5K
H-Index
38
Active since
1984
Affiliations
National Cancer Institute(Current)
Center for Cancer Research
Frederick National Laboratory for Cancer Research
Leidos (United States)
Science Applications International Corporation (United States)
Ralph E. Parchment is an author at National Cancer Institute specializing in medicine, pharmacology, and cancer research.
Top concepts
MedicinePharmacologyCancer ResearchOncologyCell BiologyTumor BiologyRadiation OncologyPharmacotherapyPathologyCancer Therapy
Publications per year
1984–2025
Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
Shivaani Kummar, Robert J. Kinders, Martin Gutierrez et al. · Journal of Clinical Oncology · 2009 · 324 citations · Full text
Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
Janet Dancey, Kevin K. Dobbin, Susan Groshen et al. · Clinical Cancer Research · 2010 · 254 citations · Full text
Biomarker Studies, Novel Agents, Biomarker (Medicine) +17
Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas
Shivaani Kummar, Alice P. Chen, Jiuping Ji et al. · Cancer Research · 2011 · 252 citations
Hydrogen peroxide as a mediator of programmed cell death in the blastocyst
G. Barry Pierce, Ralph E. Parchment, Andrea L. Lewellyn · Differentiation · 1991 · 205 citations
Reductive Stress, Developmental Biology, Cell Division +12
A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas
Shivaani Kummar, Jiuping Ji, Robert J. Morgan et al. · Clinical Cancer Research · 2012 · 201 citations · Full text
1–5 of 88